{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:43:44Z","timestamp":1792593824976,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,20]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>In situations where high-quality external data are available or when it is challenging to recruit participants to the control arm of a randomized and controlled clinical trial (eg rare or pediatric diseases), it is desirable to borrow information from external data to augment the control arm. However, a main challenge in borrowing information from external data is to accommodate potential heterogeneous subpopulations across the external and trial data. We apply a Bayesian nonparametric model called the Shared Atoms Model (SAM) to identify overlapping and unique subpopulations across datasets, with which we restrict the information borrowing to the common subpopulations. This forms a hybrid control (HC) that leads to more precise estimation of treatment effects. The degree of information borrowing is confined by the sample size and degree of similarity in outcomes. Simulation studies demonstrate the robustness of the new method, and an application to an Atopic Dermatitis dataset shows improved treatment effect estimation.<\/jats:p>","DOI":"10.1093\/biostatistics\/kxag003","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:58:59Z","timestamp":1773838739000},"source":"Crossref","is-referenced-by-count":0,"title":["SAM-HC: a Bayesian nonparametric construction of hybrid control for randomized clinical trials using external data"],"prefix":"10.1093","volume":"27","author":[{"given":"Dehua","family":"Bi","sequence":"first","affiliation":[{"name":"Department of Public Health Sciences, The University of Chicago , IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Statistics, Colorado State University , CO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-7902","authenticated-orcid":false,"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[{"name":"Oncology Biostatistics, Pfizer Inc ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, The University of Chicago , IL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"2026102110221741100_kxag003-B1","doi-asserted-by":"crossref","first-page":"ujae083","DOI":"10.1093\/biomtc\/ujae083","article-title":"Leap: the latent exchangeability prior for borrowing information from historical data","volume":"80","author":"Alt","year":"2024","journal-title":"Biometrics"},{"key":"2026102110221741100_kxag003-B2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/10543406.2021.2011904","article-title":"Bayesian divide-and-conquer propensity score based approaches for leveraging real world data in single arm clinical trials","volume":"32","author":"Baron","year":"2022","journal-title":"J Biopharm Stat"},{"key":"2026102110221741100_kxag003-B3","author":"Bi","year":"2023"},{"key":"2026102110221741100_kxag003-B4","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1002\/sim.9936","article-title":"Beats: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints","volume":"42","author":"Bi","year":"2023","journal-title":"Stat Med"},{"key":"2026102110221741100_kxag003-B5","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1080\/01621459.2023.2231581","article-title":"Bayesian nonparametric common atoms regression for generating synthetic controls in clinical trials","volume":"118","author":"Chandra","year":"2023","journal-title":"J Am Stat Assoc"},{"key":"2026102110221741100_kxag003-B6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/10543406.2020.1730877","article-title":"Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data","volume":"30","author":"Chen","year":"2020","journal-title":"J Biopharm Stat"},{"key":"2026102110221741100_kxag003-B7","author":"Chipman","year":"2010"},{"key":"2026102110221741100_kxag003-B8","author":"FDA, US","year":"2023"},{"key":"2026102110221741100_kxag003-B9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1198\/106186002760180518","article-title":"A computational approach for full nonparametric Bayesian inference under Dirichlet process mixture models","volume":"11","author":"Gelfand","year":"2002","journal-title":"J Comput Graph Stat"},{"key":"2026102110221741100_kxag003-B10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/01.wnl.0000438226.10353.1c","article-title":"The questionable use of unequal allocation in confirmatory trials","volume":"82","author":"Hey","year":"2014","journal-title":"Neurology"},{"key":"2026102110221741100_kxag003-B11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1214\/12-BA722","article-title":"Commensurate priors for incorporating historical information in clinical trials using general and generalized linear models","volume":"7","author":"Hobbs","year":"2012","journal-title":"Bayesian Anal"},{"key":"2026102110221741100_kxag003-B12","first-page":"313","author":"Horn","year":"1990"},{"key":"2026102110221741100_kxag003-B13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01908075","article-title":"Comparing partitions","volume":"2","author":"Hubert","year":"1985","journal-title":"J Classif"},{"key":"2026102110221741100_kxag003-B14","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1002\/sim.8970","article-title":"Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials","volume":"40","author":"Hupf","year":"2021","journal-title":"Stat Med"},{"key":"2026102110221741100_kxag003-B15","first-page":"46","article-title":"Power prior distributions for regression models","author":"Ibrahim","year":"2000","journal-title":"Stat Sci"},{"key":"2026102110221741100_kxag003-B16","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1080\/03610928908830127","article-title":"The overlapping coefficient as a measure of agreement between probability distributions and point estimation of the overlap of two normal densities","volume":"18","author":"Inman","year":"1989","journal-title":"Commun Stat Theory Methods"},{"key":"2026102110221741100_kxag003-B17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/pan.2019.11","article-title":"Why propensity scores should not be used for matching","volume":"27","author":"King","year":"2019","journal-title":"Polit Anal"},{"key":"2026102110221741100_kxag003-B18","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1002\/sim.9095","article-title":"Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data","volume":"40","author":"Liu","year":"2021","journal-title":"Stat Med"},{"key":"2026102110221741100_kxag003-B19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/10543406.2021.1998098","article-title":"Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources","volume":"32","author":"Lu","year":"2022","journal-title":"J Biopharm Stat"},{"key":"2026102110221741100_kxag003-B20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jmva.2006.11.013","article-title":"Comparing clusterings\u2014an information based distance","volume":"98","author":"Meil\u0103","year":"2007","journal-title":"J Multivar Anal"},{"key":"2026102110221741100_kxag003-B21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S0963548302005163","article-title":"Poisson\u2013Dirichlet and gem invariant distributions for split-and-merge transformations of an interval partition","volume":"11","author":"Pitman","year":"2002","journal-title":"Combinator Probab Comp"},{"key":"2026102110221741100_kxag003-B22","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/biom.12242","article-title":"Robust meta-analytic-predictive priors in clinical trials with historical control information","volume":"70","author":"Schmidli","year":"2014","journal-title":"Biometrics"},{"key":"2026102110221741100_kxag003-B23","author":"Schwartz","year":"2024"},{"key":"2026102110221741100_kxag003-B24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/jamadermatol.2022.0029","article-title":"Efficacy and safety of upadacitinib in patients with moderate to severe atopic dermatitis: analysis of follow-up data from the measure up 1 and measure up 2 randomized clinical trials","volume":"158","author":"Simpson","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2026102110221741100_kxag003-B25","article-title":"Sharing clusters among related groups: Hierarchical dirichlet processes","author":"Teh","year":"2004","journal-title":"Advances in Neural Information Processing Systems 17"},{"key":"2026102110221741100_kxag003-B26","author":"US FDA","year":"2018"},{"key":"2026102110221741100_kxag003-B27","author":"Wang","year":"2022"},{"key":"2026102110221741100_kxag003-B28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1162\/003465304323023705","article-title":"Using matching to estimate treatment effects: data requirements, matching metrics, and monte carlo evidence","volume":"86","author":"Zhao","year":"2004","journal-title":"Rev Econ Stat"},{"key":"2026102110221741100_kxag003-B29","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1002\/sim.9191","article-title":"Incorporating external data into the analysis of clinical trials via bayesian additive regression trees","volume":"40","author":"Zhou","year":"2021","journal-title":"Stat Med"}],"container-title":["Biostatistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biostatistics\/article-pdf\/27\/1\/kxag003\/68079206\/kxag003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biostatistics\/article-pdf\/27\/1\/kxag003\/68079206\/kxag003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:22:24Z","timestamp":1792592544000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biostatistics\/article\/doi\/10.1093\/biostatistics\/kxag003\/8653855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,20]]}},"URL":"https:\/\/doi.org\/10.1093\/biostatistics\/kxag003","relation":{},"ISSN":["1465-4644","1468-4357"],"issn-type":[{"value":"1465-4644","type":"print"},{"value":"1468-4357","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"kxag003"}}